lncRNA RP11-624L4.1 Is Associated with Unfavorable Prognosis and Promotes Proliferation via the CDK4/6-Cyclin D1-Rb-E2F1 Pathway in NPC
2020 · Molecular Therapy — Nucleic Acids · 49 citations
https://doi.org/10.1016/j.omtn.2020.10.017
R
Ruijie Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
640
Citations
11
h-index
11
i10-index
Ruijie Liu is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Antibiotic Resistance in Bacteria & Shoulder Injury and Treatment. The author has an h-index of 11, co-authored 23 publications.
ORCID: 0000-0003-2926-3296Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat